Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : VOLTAIRE'S PORCH-MODERATED -- Ignore unavailable to you. Want to Upgrade?

To: Jim Willie CB who wrote (39203)	7/18/2001 11:34:32 AM
From: stockman_scott	Read Replies (2) \| Respond to of 65232

Biotech is very complex...I totally agree. There are great risks investing in the biomedical space. Yet, some of the firms have outstanding management and really know how to execute in tough times. As an example, here's a new earnings release from MEDM (one of my investments)... biz.yahoo.com I like that type of performance in this difficult economic time period. It will be interesting to hear what the MEDM management has to say on their conf. call later today. Forward guidance is always key. Best Regards, Scott